The following government grants in the FederalGrants.com database contain the term National Institutes of Health in the listing.
Grants are sorted newest to oldest. Select a grant title to view the complete details, including information on who to contact and how to apply.
| Grant Title | CFDA | Funding Number |
| Innovation Grants to Nurture Initial Translational Efforts (IGNITE): Neurotherapeutic Agent Characterization and In vivo Efficacy Studies (R61/R33 Clinical Trial Not Allowed) |
93.853 |
PAR-25-058 |
| Environmental Health Disparities Centers (P50) Clinical Trial Optional |
93.113, 93.307, 93.361, 93.393, 93.865, 93.866 |
RFA-MD-24-010 |
| NIDCD Early Career Research(ECR) Award (R21 Clinical Trial Optional) |
93.173 |
PAR-25-120 |
| NCI Small Grants Program for Cancer Research (NCI Omnibus) (R03 Clinical Trial Optional) |
93.393 |
PAR-25-078 |
| TMD Collaborative for IMproving PAtient-Centered Translational Research (TMD IMPACT) (U54 Clinical Trial Optional) |
93.121, 93.213, 93.286, 93.313, 93.846, 93.853 |
RFA-DE-25-003 |
| Co-infection and Cancer (R01 Clinical Trial Not Allowed) |
93.393 |
PAR-25-082 |
| Screening, Brief Intervention and Referral to Treatment or Prevention (SBIRT/P) for alcohol, tobacco, and other drugs (ATOD) use and misuse in adult populations that experience health disparities (R01, Clinical Trial Required) |
93.121, 93.273, 93.279, 93.307, 93.313, 93.399 |
PAR-26-001 |
| Towards a Better Understanding of the Neurological Effects of Infection-Associated Chronic Illnesses (R01 - Clinical Trial Optional) |
93.242, 93.853 |
PAR-25-116 |
| Towards a Better Understanding of the Neurological Effects of Infection-Associated Chronic Illnesses (R21 - Clinical Trial Optional) |
93.242, 93.853 |
PAR-25-115 |
| Emerging Global Leader Award (K43 Independent Clinical Trial Not Allowed) |
93.113, 93.121, 93.172, 93.173, 93.233, 93.242, 93.279, 93.313, 93.398, 93.837, 93.838, 93.839, 93.840, 93.853, 93.866, 93.867, 93.989 |
PAR-24-296 |
| Building Biomedical Engineering Education, Research, and Innovation at Historically Black Colleges and Universities (HBCU eBETA) (UG3/UH3 Clinical Trial Not Allowed) |
93.286 |
RFA-EB-25-002 |
| Data Coordinating Center for NCCIH Multi-Site Investigator-Initiated Clinical Trials of Mind and Body Interventions (Collaborative U24 Clinical Trial Required) |
93.213 |
PAR-24-276 |
| Emerging Global Leader Award (K43 Independent Clinical Trial Required) |
93.113, 93.172, 93.173, 93.233, 93.242, 93.279, 93.313, 93.398, 93.837, 93.838, 93.839, 93.840, 93.853, 93.866, 93.989 |
PAR-24-295 |
| New Therapeutic Strategies for Genital Herpes (R21/R33 Clinical Trial Not Allowed) |
93.855 |
RFA-AI-24-068 |
| Assay Validation of High Quality Markers for Clinical Studies in Cancer (UH2/UH3 Clinical Trial Not Allowed) |
93.394 |
PAR-25-074 |
| Ending the Epidemic: New Models of Integrated HIV/AIDS, Addiction, and Primary Care Services (R01 Clinical Trial required) |
93.279 |
RFA-DA-25-072 |
| Ending the Epidemic: New Models of Integrated HIV/AIDS, Addiction, and Primary Care Services (R34 Clinical Trial Optional) |
93.279 |
RFA-DA-25-070 |
| Assay Validation of High Quality Markers for Clinical Studies in Cancer (UH3 Clinical Trials Not Allowed) |
93.394 |
PAR-25-075 |
| Human Brain Single-cell Genomics Explorer (U24 - Clinical Trial Not Allowed) |
93.113, 93.121, 93.213, 93.242, 93.273, 93.279, 93.286, 93.853, 93.865, 93.866, 93.867 |
RFA-NS-24-038 |
| Interventions to expand cancer screening and preventive services to ADVANCE health in populations that experience health disparities (R01, Clinical Trial Required) |
93.121, 93.307, 93.313, 93.399 |
PAR-25-098 |
| Continuation or Revision of NIDCR Clinical Trial Planning and Implementation Cooperative Agreement (UH3 Clinical Trial Required) |
93.121 |
PAR-25-062 |
| Single Source: NCI National Clinical Trials Network - Canadian Collaborating Clinical Trials Network (U10 Clinical Trial Required) |
93.394, 93.395 |
RFA-CA-24-032 |
| NCI National Clinical Trials Network - Network Lead Academic Participating Sites (UG1 Clinical Trial Not Allowed) |
93.394, 93.395 |
RFA-CA-24-033 |
| Revision Applications for Validation of Biomarker Assays Developed Through NIH-Supported Research Grants (R01 Clinical Trial Not Allowed) |
93.394 |
PAR-24-304 |
| Limited Competition: NCI National Clinical Trials Network - Network Group Operations Centers (U10 Clinical Trial Required) |
93.394, 93.395 |
RFA-CA-24-030 |
| Epidemiologic Research on Emerging Risk Factors and Liver Cancer Susceptibility (R01 Clinical Trial Not Allowed) |
93.393 |
PA-25-121 |
| Epidemiologic Research on Emerging Risk Factors and Liver Cancer Susceptibility (R21 Clinical Trial Not Allowed) |
93.393 |
PA-25-123 |
| Single Source: NCI National Clinical Trials Network - Network Radiotherapy and Imaging Core Services Center (U24 Clinical Trial Not Allowed) |
93.394, 93.395 |
RFA-CA-24-034 |
| NCI National Clinical Trials Network - Network Group Integrated Translational Science Centers (UG1 Clinical Trial Not Allowed) |
93.394, 93.395 |
RFA-CA-24-035 |
| Limited Competition: NCI National Clinical Trials Network - Network Group Statistics and Data Management Centers (U10 Clinical Trial Required) |
93.394, 93.395 |
RFA-CA-24-031 |
| HEAL Initiative: Understanding Individual Differences in Human Pain Conditions (R01 - Clinical Trial Optional) |
93.213, 93.233, 93.279, 93.395, 93.837, 93.838, 93.839, 93.840, 93.846, 93.853, 93.865, 93.866, 93.867 |
RFA-NS-25-020 |
| Centers on the Demography and Economics of Aging, Including Alzheimer's Disease and Alzheimer's Disease-Related Dementias (AD/ADRD) (D and E Centers) (P30 Clinical Trial Optional) |
93.866 |
RFA-AG-25-007 |
| Development of Alternative Human Models of Radiation-Induced Injuries (Extracorporeal Systems) (U01 Clinical Trial Not Allowed) |
93.855 |
RFA-AI-24-067 |
| Centers for Precision Disease Modeling (U54) (Clinical Trials Not Allowed) |
93.351 |
PAR-24-305 |
| Centers on the Demography and Economics of Aging and Alzheimers Disease and Alzheimers Disease-Related Dementias Coordinating Center (U24 Clinical Trial Optional) |
93.866 |
RFA-AG-25-008 |
| Limited Competition: CCRP Initiative: Promoting a Basic Understanding of Chemical Threats to Skin (R34 Clinical Trial Not Allowed) |
93.846, 93.855 |
PA-25-093 |
| Analytical Validation of a Candidate Biomarker for Neurological or Neuromuscular Disorders(U01 Clinical Trial Optional) |
93.853 |
PAR-25-050 |
| Scaling-up and Maintaining Evidence-based Interventions to Maximize Impact on Cancer (SUMMIT)- Lung Cancer Screening (UG3/UH3 Clinical Trial Required) |
93.399 |
RFA-CA-25-009 |
| Scaling-up and Maintaining Evidence-based Interventions to Maximize Impact on Cancer (SUMMIT) - Tobacco Use Treatment for Cancer Survivors (UG3/UH3 Clinical Trial Required) |
93.399 |
RFA-CA-25-010 |
| NIH Support for Conferences and Scientific Meetings (Parent R13 Clinical Trial Not Allowed) |
93.172, 93.213, 93.310, 93.350, 93.846, 93.853, 93.855, 93.859, 93.867, 93.879 |
PA-25-080 |
Search Results 601-640 of 15475
[Prev] 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60 61 62 63 64 65 66 67 68 69 70 71 72 73 74 75 76 77 78 79 80 81 82 83 84 85 86 87 88 89 90 91 92 93 94 95 96 97 98 99 100 101 102 103 104 105 106 107 108 109 110 111 112 113 114 115 116 117 118 119 120 121 122 123 124 125 126 127 128 129 130 131 132 133 134 135 136 137 138 139 140 141 142 143 144 145 146 147 148 149 150 151 152 153 154 155 156 157 158 159 160 161 162 163 164 165 166 167 168 169 170 171 172 173 174 175 176 177 178 179 180 181 182 183 184 185 186 187 188 189 190 191 192 193 194 195 196 197 198 199 200 201 202 203 204 205 206 207 208 209 210 211 212 213 214 215 216 217 218 219 220 221 222 223 224 225 226 227 228 229 230 231 232 233 234 235 236 237 238 239 240 241 242 243 244 245 246 247 248 249 250 251 252 253 254 255 256 257 258 259 260 261 262 263 264 265 266 267 268 269 270 271 272 273 274 275 276 277 278 279 280 281 282 283 284 285 286 287 288 289 290 291 292 293 294 295 296 297 298 299 300 301 302 303 304 305 306 307 308 309 310 311 312 313 314 315 316 317 318 319 320 321 322 323 324 325 326 327 328 329 330 331 332 333 334 335 336 337 338 339 340 341 342 343 344 345 346 347 348 349 350 351 352 353 354 355 356 357 358 359 360 361 362 363 364 365 366 367 368 369 370 371 372 373 374 375 376 377 378 379 380 381 382 383 384 385 386 387 [Next] |
